Zobrazeno 1 - 10 of 426 pro vyhledávání: '"Imbergamo, S"'
1
Akademický článek
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Autor: Lazzarotto D; Clinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. davide.lazzarotto@asufc.sanita.fvg.it., Cerrano M; S.C. Ematologia, AOU Citta della Salute e della Scienza - Presidio Molinette, Torino, Italy., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seragnoli', Bologna, Italy., Chiaretti S; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, 'Sapienza' Universita di Roma, Roma, Italy., Mosna F; Ematologia e Centro Trapianti di Midollo Osseo, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Fracchiolla N; U.O. Ematologia, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Italy., Zappasodi P; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Imbergamo S; Dipartimento Strutturale Aziendale Medicina, University of Padova, Padova, Italy., Del Principe MI; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy., Lunghi M; Division of Hematology, Department of Translational Medicine, AOU Maggiore della Carita, Universita del Piemonte Orientale, Novara, Italy., Lussana F; Hematology and Bone Marrow Transplantation Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Piccini M; SODc Ematologia, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy., Fumagalli M; Ematologia, Ospedale San Gerardo, ATS Brianza, Monza, Italy., Dargenio M; S.C. Ematologia, Ospedale Vito Fazzi, Lecce, Italy., Salutari P; Hematology Unit, Ospedale Civile Santo Spirito, Pescara, Italy., Forghieri F; Clinica Ematologica, Azienda Ospedaliero Universitaria di Modena, Dip. Scienze Mediche e Chirurgiche, UNIMORE, Modena, Italy., Da Molin TG; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy; Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Bonifacio M; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy; Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Olivi M; Department of Oncology and Hematology, A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy., Giglio F; Unita Di Ematologia E Trapianto Di Midollo Osseo, IRCCS Ospedale San Raffaele di Milano, Milano, Italy., Trappolini S; S.O.D. Clinica Ematologica, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, Ancona, Italy., Leoncin M; UOC Ematologia, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Mestre, Italy., Mule A; Divisione di Ematologia ad indirizzo oncologico, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Delia M; UO Ematologia con Trapianto - Azienda Ospedaliero-Universitaria-Consorziale Policlinico di Bari, Bari, Italy., Pasciolla C; U.O. di Ematologia, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Grimaldi F; Dipartimento di Medicina Clinica e Chirurgia, AOU Federico II, Napoli, Italy., Cambo B; Hematology and BMT Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy., Santoro L; U.O.C. Ematologia e Trapianto di Midollo Osseo, Avellino, Italy., Guolo F; Clinica Ematologica, Dipartimento Di Medicina Interna (DiMI), Universita Degli Studi di Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Minetto P; Clinica Ematologica, Dipartimento Di Medicina Interna (DiMI), Universita Degli Studi di Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Defina M; UOC Ematologia, Azienda Ospedaliero Universitaria Senese, Siena, Italy., Chiusolo P; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universita Cattolica del Sacro Cuore, Roma, Italy., Fanin M; Clinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Dipartimento di Medicina, Universita degli Studi di Udine, Udine, Italy., Mauro E; Hematology Unit, Santa Maria di Ca' Foncello Hospital, Treviso, Italy., Aprile L; S.C. Ematologia, Ospedale S.G. Moscati, Taranto, Italy., Mazzone C; Haematology, Department of Medical Area, St. Eugenio Hospital, Roma, Italy., Trastulli F; Hematology, Hospital 'Antonio Cardarelli', Napoli, Italy., Ciccone M; UO Ematologia, Dipartimento di Medicine Specialistiche, Azienda Ospedaliero-Universitaria Arcispedale S Anna, Ferrara, Italy., De Gobbi M; Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy., Cignetti A; SCDU Ematologia e Terapie Cellulari, AO Ordine Mauriziano, Torino, Italy., De Bellis E; UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Mancini V; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Piciocchi A; Centro Dati Fondazione GIMEMA Franco Mandelli, Roma, Italy., Vignetti M; Centro Dati Fondazione GIMEMA Franco Mandelli, Roma, Italy., Marsili G; Centro Dati Fondazione GIMEMA Franco Mandelli, Roma, Italy., Starza ID; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, 'Sapienza' Universita di Roma, Roma, Italy; Centro Dati Fondazione GIMEMA Franco Mandelli, Roma, Italy., Fanin R; Clinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Dipartimento di Medicina, Universita degli Studi di Udine, Udine, Italy., Luppi M; Clinica Ematologica, Azienda Ospedaliero Universitaria di Modena, Dip. Scienze Mediche e Chirurgiche, UNIMORE, Modena, Italy., Ferrara F; Hematology, Hospital 'Antonio Cardarelli', Napoli, Italy., Pizzolo G; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy; Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Bassan R; UOC Ematologia, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Mestre, Italy., Foa R; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, 'Sapienza' Universita di Roma, Roma, Italy., Candoni A; Clinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Clinica Ematologica, Azienda Ospedaliero Universitaria di Modena, Dip. Scienze Mediche e Chirurgiche, UNIMORE, Modena, Italy.
Publikováno v: Haematologica [Haematologica] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.
Zobrazit plný text záznamu
2
Editorial & Opinion
Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient.
Autor: Briani C; Department of Neurosciences, University of Padova, Via Giustiniani 5, 35128, Padua, Italy. chiara.briani@unipd.it., Salvalaggio A; Department of Neurosciences, University of Padova, Via Giustiniani 5, 35128, Padua, Italy., Anglani M; Neuroradiology Unit, Padova University Hospital, Padua, Italy., Imbergamo S; Hematology and Immunological Unit, Department of Medicine, University of Padova, Padua, Italy., Pravato S; Hematology and Immunological Unit, Department of Medicine, University of Padova, Padua, Italy., Marasca M; Department of Neurosciences, University of Padova, Via Giustiniani 5, 35128, Padua, Italy., Cacciavillani M; CEMES, Data Medica Group, Padua, Italy., Gasparotti R; Neuroradiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy.
Publikováno v: Journal of neurology [J Neurol] 2024 Mar; Vol. 271 (3), pp. 1080-1083. Date of Electronic Publication: 2024 Jan 07.
Zobrazit plný text záznamu
3
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
Autor: Visentin A, Frezzato F, Severin F, Imbergamo S, Pravato S, Romano Gargarella L, Manni S, Pizzo S, Ruggieri E, Facco M, Brunati AM, Semenzato G, Piazza F, Trentin L
Publikováno v: OncoTargets and Therapy, Vol Volume 13, Pp 9679-9688 (2020)
Andrea Visentin,1,2 Federica Frezzato,1,2 Filippo Severin,1,2 Silvia Imbergamo,1 Stefano Pravato,1 Leila Romano Gargarella,1 Sabrina Manni,1,2 Serena Pizzo,1,2 Edoardo Ruggieri,1,2 Monica Facco,1,2 Anna Maria Brunati,3 Gianpietro Semenzato,1,2 France
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::7d4231a427ffb0a2000ecfd6657e41d2
https://www.dovepress.com/lights-and-shade-of-next-generation-pi3k-inhibitors-in-chronic-lymphoc-peer-reviewed-article-OTT
Zobrazit plný text záznamu
6
Akademický článek
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Autor: Angotzi F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Petrella M; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Berno T; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Binotto G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Bonetto G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Branca A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Carraro M; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Cavaretta CA; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Cellini A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., D'Amore F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Forlani L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Gianesello I; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Gurrieri C; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Imbergamo S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Lessi F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Maroccia A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Mazzetto F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pavan L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pezone S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Piazza F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Pravato S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Ruocco V; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Scapinello G; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Vianello F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zambello R; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zatta I; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Zoletto S; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Padoan A; Department of Integrated Diagnostic Medicine, Laboratory Medicine Unit, University of Padova, Padova, Italy., Trentin L; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy., Visentin A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy.
Publikováno v: Frontiers in oncology [Front Oncol] 2023 Jun 22; Vol. 13, pp. 1212752. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
Zobrazit plný text záznamu
7
Akademický článek
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Autor: Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy.; Hematology Unit, Department of Medicine of Systems (DIDAS), Azienda Ospedale Università Padova, 35128 Padova, Italy., Molinari MC; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, 00185 Rome, Italy., Pravato S; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Cellini A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Angotzi F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Cavaretta CA; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Ruocco V; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Imbergamo S; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Piazza F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy., Proietti G; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, 00185 Rome, Italy., Mauro FR; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, 00185 Rome, Italy., Trentin L; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy.; Hematology Unit, Department of Medicine of Systems (DIDAS), Azienda Ospedale Università Padova, 35128 Padova, Italy.
Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 25; Vol. 30 (1), pp. 274-283. Date of Electronic Publication: 2022 Dec 25.
Zobrazit plný text záznamu
8
Akademický článek
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Autor: Voso MT; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Pandzic T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Falconi G; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Denčić-Fekete M; Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia., De Bellis E; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Scarfo L; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Iskas M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Del Poeta G; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Ranghetti P; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy., Laidou S; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Cristiano A; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Plevova K; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital Brno, Brno, Czech Republic., Imbergamo S; Hematology and Clinical Immunology, Department of Hematology, Hospital of Padua, Padua, Italy., Engvall M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Salvetti C; Division of Hematology, University of Turin, Turin, Italy., Mauro FR; Department of Translational and Precision Medicine, Hematology, 'Sapienza' University, Rome, Italy., Stavroyianni N; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Cavelier L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Ghia P; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Fabiani E; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v: British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 103-113. Date of Electronic Publication: 2022 Mar 11.
Zobrazit plný text záznamu
9
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
Autor: De Bellis E; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy. Electronic address: eleonora.debellis@asugi.sanita.fvg.it., Imbergamo S; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Candoni A; Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy., Liço A; Hematology Department, San Bortolo Hospital, Azienda ULSS8 'Berica' of Vicenza, Vicenza, Italy., Tanasi I; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Mauro E; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, Treviso, Italy., Mosna F; Ematologia e CTMO - Ospedale Regionale 'S. Maurizio', Comprensorio Sanitario di Bolzano, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Leoncin M; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy., Stulle M; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Griguolo D; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Pravato S; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Trentin L; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Lazzarotto D; Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy., Di Bona E; AULSS7 Pedemontana, U.O.C. Oncoematologia, Bassano del Grappa (VI), Italy., Sancetta R; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy., Lucchini E; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Poiani M; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Palmieri C; Presidio Ospedaliero Ospedale Maggiore, Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy., Zaja F; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.
Publikováno v: Leukemia research [Leuk Res] 2022 Apr; Vol. 115, pp. 106811. Date of Electronic Publication: 2022 Feb 24.
Zobrazit plný text záznamu
10
Akademický článek
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
Autor: De Bellis E; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy. Electronic address: eleonora.debellis@asugi.sanita.fvg.it., Imbergamo S; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Candoni A; Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy., Liço A; Hematology Department, San Bortolo Hospital, Azienda ULSS8 'Berica' of Vicenza, Vicenza, Italy., Tanasi I; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Mauro E; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, Treviso, Italy., Mosna F; Ematologia e CTMO - Ospedale Regionale 'S. Maurizio', Comprensorio Sanitario di Bolzano, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Leoncin M; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy., Stulle M; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Griguolo D; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Pravato S; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Trentin L; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Italy., Lazzarotto D; Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy., Di Bona E; AULSS7 Pedemontana, U.O.C. Oncoematologia, Bassano del Grappa (VI), Italy., Bassan R; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy., Lucchini E; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Poiani M; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Palmieri C; Presidio Ospedaliero Ospedale Maggiore, Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy., Zaja F; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.
Publikováno v: Leukemia research [Leuk Res] 2022 Mar; Vol. 114, pp. 106803. Date of Electronic Publication: 2022 Feb 08.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje